Jushi: Canaccord Raises Estimates Following Nature’s Remedy Acquisition

On September 13th, Jushi Holdings (CSE: JUSH) announced that they completed their acquisition of Nature’s Remedy for a slightly reduced $91.2 in million total consideration, instead of the original $100 million agreed upon. The company reduced the number of shares issued to 8.7 million instead of the original 11.9 million, but increased the debt component to $16.50 million.

Nature’s Remedy has a 50,000 square foot cultivation and production facility, with a 22,000 square foot “high-quality” indoor production and “state-of-the-art extraction” facility. The company expects to expand that to 32,500 square feet by the end of this year. They also operate 2 retail dispensaries.

Jushi Holdings currently has 6 analysts covering the stock with an average 12-month price target of $12.14, or a 143% upside. Out of the 6 analysts, 2 have strong buy ratings and 4 have buy ratings. The street high sits at $14 from PI Financial and the lowest comes in at $10.

Canaccord Genuity reiterated their U$8/C$10 price target and Buy rating on the stock after the news dropped. Bobby Burleson, Canaccord’s analyst, says, “With the ability to walk away based on original deal terms, management was able to negotiate a lower price and receive roughly $20m in flower inventory to boot.” The price of the deal now sits at sub 2.5x 2022 EBITDA.

With the close, Canaccord has elected to raise their full year 2021 and 2022 estimates slightly but are keeping their third quarter estimate the same.

They add that the cultivation assets acquired come with additional room for expansion, with the operation producing 16,000 pounds of biomass and 9,000 pounds of high-quality cannabis annually currently. Jushi expects to bring this number up to 26,000 pounds and 13,000 pounds, respectively. The facility is located within a 185,000 square foot complex, “which presents numerous expansion opportunities and could potentially accommodate up to an additional 18,000 to 20,000 square feet of canopy.”

Canaccord calls the two dispensaries acquired strong retail locations in “strategic locations.” with one located along the “Worcester-Providence Turnpike and is in close proximity to the Shoppes at Blackstone Valley, Central Massachusetts’s largest open-air shopping center.” While the other location is located near the Pheasant Lane Mall, which is one of the largest malls in New Hampshire.

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Related News

Haywood Reiterates $12 Price Target On Well Health

On January 20th, Well Health (TSX: WELL) provided a business update which included fourth quarter...

Monday, January 24, 2022, 04:22:00 PM

Magna: Analysts Upgrade En Masse Following Earnings Beat

On February 19th, Magna International (TSX: MG) announced its fourth quarter and full year financials...

Saturday, February 27, 2021, 01:55:00 PM

Amazon: Analysts Expect $115.1 Billion In Q2 Revenue

Amazon.com Inc (NASDAQ: AMZN) will be reporting its second quarter financial results today after markets...

Thursday, July 29, 2021, 11:24:00 AM

Enthusiast Gaming: Canaccord Updates Model Following Conference

Recently Canaccord Genuity sat down with Enthusiast Gaming’s (TSX: EGLX) C-suite to talk about the...

Friday, May 7, 2021, 03:17:00 PM

Cresco Labs: Haywood Marginally Revises Estimates Following Cultivate Acquisition

On September 3, Cresco Labs (CSE: CL) announced that they have closed their acquisition of...

Friday, September 10, 2021, 10:56:00 AM